Uniunea Europeană - română - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - diphtheria toxoid, tetanus toxoid, bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin), hepatitis b surface antigen, poliovirus (inactivated) (type-1 (mahoney strain), type-2 (mef-1 strain), type-3 (saukett strain)), haemophilus influenzae type b polysaccharide - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; poliomyelitis; diphtheria - vaccinuri - infanrix hexa este indicat pentru vaccinare primară şi de rapel a sugarilor împotriva difteriei, tetanosului, pertussis, hepatita b, poliomielită şi boală cauzată de haemophilus influenzae tip-b.

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

glaxo smithkline biologicals s.a. - belgia - vaccin rujeolic,rubeolic,urlian,varicelic,viu. - pulb+solv.pt.sol.inj. in seringa preumpluta - vaccinuri virale vaccinuri rujeolice

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

glaxosmithkline biologicals s.a. - belgia - vaccin varicelic viu atenuat - pulb.+solv. pt. sol. inj. - 10³,³ pfu /0,5 ml - vaccinuri virale vaccinuri varicelo-zoosteriene

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

panpharma - franta - kanamycinum - pulb. pt. sol. inj./perf. - 1g - antibiotice aminoglicozidice alte aminoglicozide

Uniunea Europeană - română - EMA (European Medicines Agency)

sanofi winthrop industrie - dupilumab - dermatitis, atopic; prurigo; esophageal diseases; asthma; sinusitis - agenți pentru dermatită, cu excepția corticosteroizilor - atopic dermatitisadults and adolescentsdupixent is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. children 6 months to 11 years of agedupixent is indicated for the treatment of severe atopic dermatitis in children 6 months to 11 years old who are candidates for systemic therapy. asthmaadults and adolescentsdupixent is indicated in adults and adolescents 12 years and older as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), see section 5. 1, who are inadequately controlled with high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. children 6 to 11 years of agedupixent is indicated in children 6 to 11 years old as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), who are inadequately controlled with medium to high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. chronic rhinosinusitis with nasal polyposis (crswnp)dupixent is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adults with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate disease control. prurigo nodularis (pn)dupixent is indicated for the treatment of adults with moderate-to-severe prurigo nodularis (pn) who are candidates for systemic therapy. eosinophilic esophagitis (eoe)dupixent is indicated for the treatment of eosinophilic esophagitis in adults and adolescents 12 years and older, weighing at least 40 kg, who are inadequately controlled by, are intolerant to, or who are not candidates for conventional medicinal therapy.

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

glaxosmithkline biologicals sa - belgia - vaccin rujeolic,rubeolic,urlian,varicelic,viu. - pulb. si solv. pt. sol. inj. in seringa preumpluta - vaccinuri virale vaccinuri rujeolice

Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

glaxosmithkline biologicals s.a. - vaccin difteric, tetanic, pertussis, hepatitic b, poliomielitic și haemophilus influenzae tip b - ... - pulbere şi suspensie pentru suspensie injectabilă - 1 doză

Uniunea Europeană - română - EMA (European Medicines Agency)

leo pharma a/s - tralokinumab - dermatita, atopică - alte preparate dermatologice - adtralza is indicated for the treatment of moderate to severe atopic dermatitis in adult and adolescent patients 12 years and older who are candidates for systemic therapy.

Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

dhg pharmaceutical jsc - spiramycinum - comprimate filmate - 3 mil. ui

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sanofi pasteur - franta - vaccin gripal inactivat - susp. inj. in seringa preumpluta - vaccinuri virale vaccinuri gripale